Covidien Public Limited Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. It operates its businesses through three segments: Medical Devices, which includes the development, manufacture and sale of endomechanical instruments, energy devices, soft tissue repair products, vascular products, oximetry and monitoring products, airway and ventilation products; Pharmaceuticals, which includes the development, manufacture and distribution of specialty pharmaceuticals and active pharmaceutical ingredients, and Medical Supplies, SharpSafety products and original equipment manufacturer products. In May 2012, it acquired Newport Medical Instruments, Inc. In May 2012, it acquired superDimension, Ltd. In June 2012, the Company acquired Oridion Systems Ltd. In October 2012, its Mallinckrodt acquired CNS Therapeutics, Inc. In January 2013, the Company acquired CV Ingenuity.
|Headquarters||20 Lower Hatch Street, Dublin 2|
|Chairman of the Board, President, Chief Executive Officer||Jose Almeida|
|Chief Financial Officer, Executive Vice President||Charles Dockendorff|
|Senior Vice President, General Counsel||John Masterson|
|Senior Vice President - Human Resources||Michael Dunford|
|Senior Vice President and President - Medical Supplies Business||James Clemmer|
With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.
|Shares Out.||470.5M||Book Value||$22.38|
|Annual Dividend Rate||$1.04||Price/Sales (TTM)||2.5|
|Ex-Div Date||7/1/13||P/Cash Flow (TTM)||11.9x|
|Pay Date||5/3/13||Operating Margin||19.84%|
*GAAP = prior to non-GAAP analyst adjusted earnings.